Alzamend Neuro

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Alzamend Neuro and other ETFs, options, and stocks.

About ALZN

Alzamend Neuro, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing products for the treatment of neurodegenerative and psychiatric disorders. The company's pipeline includes AL001, which is in Phase II clinical trial, and delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bipolar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders, and AL002, which completed preclinical stage, and uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. 

CEO
Stephan Jackman
CEOStephan Jackman
Employees
7
Employees7
Headquarters
Atlanta, Georgia
HeadquartersAtlanta, Georgia
Founded
2016
Founded2016
Employees
7
Employees7

ALZN Key Statistics

Market cap
3.44M
Market cap3.44M
Price-Earnings ratio
-0.21
Price-Earnings ratio-0.21
Dividend yield
Dividend yield
Average volume
366.18K
Average volume366.18K
High today
$0.9699
High today$0.9699
Low today
$0.90
Low today$0.90
Open price
$0.93
Open price$0.93
Volume
55.16K
Volume55.16K
52 Week high
$8.22
52 Week high$8.22
52 Week low
$0.8812
52 Week low$0.8812

Stock Snapshot

The current Alzamend Neuro(ALZN) stock price is $0.90, with a market capitalization of 3.44M. The stock trades at a price-to-earnings (P/E) ratio of -0.21.

As of 2026-04-10, Alzamend Neuro(ALZN) stock has fluctuated between $0.90 and $0.97. The current price stands at $0.90, placing the stock +0.3% above today's low and -6.9% off the high.

The Alzamend Neuro(ALZN)'s current trading volume is 55.16K, compared to an average daily volume of 366.18K.

In the last year, Alzamend Neuro(ALZN) shares hit a 52-week high of $8.22 and a 52-week low of $0.88.

In the last year, Alzamend Neuro(ALZN) shares hit a 52-week high of $8.22 and a 52-week low of $0.88.

ALZN News

TipRanks 3d
Alzamend Neuro’s AL001 shows “encouraging” data in Phase II brain trial

Alzamend Neuro (ALZN) announced “encouraging” pharmacodynamic findings from a brain magnetic resonance spectroscopy, or MRS, analysis conducted in six healthy h...

People also own

Based on the portfolios of people who own ALZN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.